1. Home
  2. NSPR vs NCTY Comparison

NSPR vs NCTY Comparison

Compare NSPR & NCTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InspireMD Inc.

NSPR

InspireMD Inc.

SELL

Current Price

$0.60

Market Cap

38.9M

Sector

Health Care

ML Signal

SELL

Logo The9 Limited American Depository Shares

NCTY

The9 Limited American Depository Shares

SELL

Current Price

$2.75

Market Cap

45.7M

ML Signal

SELL

Company Overview

Basic Information
Metric
NSPR
NCTY
Founded
2005
1999
Country
United States
China
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
38.9M
45.7M
IPO Year
2009
2004

Fundamental Metrics

Financial Performance
Metric
NSPR
NCTY
Price
$0.60
$2.75
Analyst Decision
Buy
Analyst Count
3
0
Target Price
★ $3.33
N/A
AVG Volume (30 Days)
★ 404.0K
38.2K
Earning Date
11-12-2026
11-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
★ N/A
Revenue
★ $2,310,000.00
N/A
Revenue This Year
$9.14
N/A
Revenue Next Year
$105.44
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.43
$2.40
52 Week High
$2.17
$8.31

Technical Indicators

Market Signals
Indicator
NSPR
NCTY
Relative Strength Index (RSI) 49.18 40.55
Support Level $0.43 $2.40
Resistance Level $0.77 $5.48
Average True Range (ATR) 0.11 0.24
MACD 0.01 0.02
Stochastic Oscillator 44.74 42.78

Price Performance

Historical Comparison
NSPR
NCTY

About NSPR InspireMD Inc.

InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.

About NCTY The9 Limited American Depository Shares

The9 Ltd operates a cryptocurrency mining business. It provides computing power, or hash rate, to a Bitcoin mining pool and is entitled to receive a fractional share of Bitcoin award from the Bitcoin mining pool in return. The company generates its revenues from customers in Greater China, Asia/Eastern Europe, and North America. Its segments are: Crypto mining business, and Online game services, out of which Crypto mining business derives maximum revenue.

Share on Social Networks: